BIIB vs DEVS · P/E 21, rev $9.89B vs rev $25.8K
Biogen Inc (BIIB) versus DevvStream Corp. Common Stock (DEVS) — a side-by-side from cached financials, not a winner call.
Biogen Inc (BIIB) is a drug manufacturers - general company listed on NASDAQ.
DevvStream Corp. Common Stock (DEVS) is a pollution & treatment controls company listed on US.
Latest reported BIIB revenue for 2025-12-31 was $9.89B. Net income was $1.29B. Revenue was up 2.2% from 2024-12-31 to 2025-12-31. BIIB currently screens at market cap $29.33B and trailing P/E 21.4.
Latest reported DEVS revenue for 2025-07-31 was $25.8K. Net income was -$12.1M. DEVS currently screens at market cap $13.4M.
BIIB currently screens at market cap $29.33B and trailing P/E 21.4. DEVS currently screens at market cap $13.4M.
Not investment advice. Open the BIIB and DEVS stock pages for the full models.
Not investment advice.